Rosen National Trial Counsel’s Playful Pep Talk to ModivCare Investors: ‘Don’t Worry, Be Happy’ (And Patient)!

Attention ModivCare Investors: Important Information Regarding Securities Class Action Lawsuit

New York, NY – In a recent development that may impact investors, Rosen Law Firm, a leading global investor rights law firm, has reminded purchasers of ModivCare Inc. (MODV) securities between November 3, 2022, and September 15, 2024 (the “Class Period”), of the significant March 31, 2025, lead plaintiff deadline in a securities class action lawsuit.

What Happened?

ModivCare is a telehealth and remote patient monitoring technology company. The lawsuit alleges that ModivCare and certain of its executives made false and misleading statements to the market, misrepresenting the company’s business, operations, and financial condition. As a result, ModivCare securities traded at artificially inflated prices during the Class Period.

Who Can Participate?

If you purchased or otherwise acquired ModivCare securities during the Class Period, you may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. The lead plaintiff deadline is fast approaching, so it is crucial that you take action if you are an affected investor.

What Does This Mean for Me?

As an affected investor, you may be eligible to recover your losses. The compensation you may receive depends on the size of your investment and the extent of your losses. Participating in a securities class action lawsuit can also help hold the company and its executives accountable for their alleged misconduct. If you wish to join the action, you must act before the lead plaintiff deadline.

What Does This Mean for the World?

Securities class action lawsuits serve an essential role in protecting investors and maintaining the integrity of the financial markets. The lawsuit against ModivCare is a reminder that companies and their executives must provide accurate and truthful information to investors. Failure to do so can result in significant consequences, including financial losses for investors and reputational damage for the company.

Conclusion

If you purchased ModivCare securities during the Class Period, you may be entitled to compensation. The lead plaintiff deadline is March 31, 2025. Contact Rosen Law Firm to discuss your potential recovery options and help ensure that you do not miss out on the opportunity to recover your losses.

  • Rosen Law Firm is a leading global investor rights law firm.
  • ModivCare is a telehealth and remote patient monitoring technology company.
  • The lawsuit alleges that ModivCare and certain of its executives made false and misleading statements to the market.
  • Affected investors may be entitled to compensation without payment of any out-of-pocket fees or costs.
  • The lead plaintiff deadline is March 31, 2025.
  • Securities class action lawsuits help protect investors and maintain the integrity of the financial markets.

Leave a Reply